PTNT Projected Dividend Yield
Palatin Technologies Inc ( OTCBB : PTNT )Palatin Technologies, Inc. is a biopharmaceutical company. Co. is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor system. Co.'s product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its new product development activities focus primarily on MC1r agonists, with the potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. 21 YEAR PERFORMANCE RESULTS |
PTNT Dividend History Detail PTNT Dividend News PTNT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |